Esperion Appoints Robert E. Hoffman to Board of Directors
ESPR Stock | USD 0.85 0.02 2.32% |
Slightly above 50% of Esperion Therapeutics' retail investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Esperion Therapeutics suggests that some traders are interested. Esperion Therapeutics' investing sentiment overview a quick insight into current market opportunities from investing in Esperion Therapeutics. Many technical investors use Esperion Therapeutics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
- Veteran Industry Executive Brings Decades of Financial and Leadership Experience - ANN ARBOR, Mich., April 01, 2025 -- Esperion to
Read at gurufocus.com
![]() |
Esperion Therapeutics Current Investor Sentiment
Comfort Level 50
Impartial
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Esperion Therapeutics' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Esperion Therapeutics.
News SentimentBullish | Hype SentimentBearish | Insider SentimentDisposing |
Esperion Therapeutics Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Esperion Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Esperion Therapeutics Historical Investor Sentiment
Investor biases related to Esperion Therapeutics' public news can be used to forecast risks associated with an investment in Esperion. The trend in average sentiment can be used to explain how an investor holding Esperion can time the market purely based on public headlines and social activities around Esperion Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Esperion Therapeutics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Esperion Therapeutics and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Esperion Therapeutics news discussions. The higher the estimate score, the more favorable the investor's outlook on Esperion Therapeutics.
Esperion Therapeutics Fundamental Analysis
We analyze Esperion Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Esperion Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Esperion Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Market Capitalization
Market Capitalization Comparative Analysis
Esperion Therapeutics is currently under evaluation in market capitalization category among its peers. Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Esperion Therapeutics Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Esperion Therapeutics stock to make a market-neutral strategy. Peer analysis of Esperion Therapeutics could also be used in its relative valuation, which is a method of valuing Esperion Therapeutics by comparing valuation metrics with similar companies.
Peers
Esperion Therapeutics Related Equities
RMTI | Rockwell Medical | 4.26 | ||||
PBH | Prestige Brand | 1.41 | ||||
ALKS | Alkermes Plc | 1.19 | ||||
ANIP | ANI Pharmaceuticals | 0.79 | ||||
ELAN | Elanco Animal | 0.30 | ||||
COLL | Collegium Pharmaceutical | 0.14 | ||||
KMDA | Kamada | 0.29 | ||||
PCRX | Pacira BioSciences, | 0.35 | ||||
NBIX | Neurocrine Biosciences | 0.52 | ||||
PAHC | Phibro Animal | 0.97 | ||||
LFCR | Lifecore Biomedical | 1.17 | ||||
AVDL | Avadel Pharmaceuticals | 1.19 | ||||
SIGA | SIGA Technologies | 2.92 | ||||
IRWD | Ironwood Pharmaceuticals | 4.76 |
Additional Tools for Esperion Stock Analysis
When running Esperion Therapeutics' price analysis, check to measure Esperion Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Esperion Therapeutics is operating at the current time. Most of Esperion Therapeutics' value examination focuses on studying past and present price action to predict the probability of Esperion Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Esperion Therapeutics' price. Additionally, you may evaluate how the addition of Esperion Therapeutics to your portfolios can decrease your overall portfolio volatility.